CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005696
NCT00005696N/ACompleted
CompareCT.gov

Early Atherosclerosis Change in Two Clinical Trials

National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Feb 29, 2016

In Brief

An observational study for Cardiovascular Diseases and 4 related conditions. Completed.

Detailed Summary

To complete end point analysis for the Monitored Atherosclerosis Regression Study (MARS) and to compare coronary versus carotid treatment effect relationships in MARS to coronary versus carotid treatment effect relationships in the Cholesterol Lowering Atherosclerosis Study (CLAS). Both MARS and CLAS were serial arterial imaging trials that explored the reversibility of atherosclerosis with lipid-lowering therapy in native coronary, carotid, and femoral arterial beds, as well as in coronary artery bypass grafts.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Carotid Artery Diseases, Coronary Disease, Atherosclerosis
Countries--
Collaborators--

Timeline

N/ACompletedFinished
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartJan 1, 1994
Study CompletionDec 1, 1996
TodayJul 2, 2026
Posted 26.1 years ago